|
It was reported that the patient presented post triple coronary artery bypass and hemodynamics were declining.A severe st elevation was noted, prompting the selection of the impella rp for use in this patient.During acute myocardial infarction/cardiogenic shock procedure, 23 fr introducer was inserted in the patient and a kink was identified midway up the device.The impella rp was inserted through the introducer, but could not successfully cross into the ventricle for proper placement.The impella device was found damaged upon removal and the physician did not feel comfortable removing the introducer, so vascular surgery was consulted.The vascular surgeon removed the introducer and closed the site, however, a perforation was found in the patient's vein was found.The perforation was alleged to have been caused by the kinked introducer.No additional information is available and no other adverse event reported.
|
|
The device was used for treatment.The device was not returned for analysis, therefore, the clinical observation could not be confirmed.However, vascular perforation was repaired and impella was delivered.Potential contributing factors to the kinks could be if the sheath was advanced through an area of resistance or patient anatomy could have contributed to the kink.The investigation was focus on a review of product documentation.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections.Following controls are in place to mitigate the reported product issue.Per procedure abiomed introducer sheath in-process and final inspection: measure dimensions: measure tip i.D.Of sheath using appropriate pin gauges to be in range of 0.305" - 0.307" for 23f.Visual inspection: using 10x magnification, verify the tip is round, no flash protruding greater than 0.4 mm (0.016") and no flash with width (around circumference) greater than 0.7 mm (0.028"), no splitting, cracks or other damages.Visual inspection, with naked eye at a distance of 12" to 18", verify the assembled sheath matches the drawing.Ensure parts are free of kinks, cracks, splits, sinks, excessive flash, loose/embedded fm, or any other damages.Per ifu : never advance or withdraw guidewire or sheath when resistance is met.Determine cause by fluoroscopy and take remedial action.When injecting or aspirating through the sheath, use the sideport only.Avoid subjecting the device to unusual stresses.When assembling the sheath and dilator, care must be taken to insert the dilator tip straight through the center of the valve membrane in order to prevent inadvertent puncturing of the membrane based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.In addition, there was no new failure mode identified and the risk remains acceptable.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|